Skip to main content
. 2022 Sep 5;10(5):1982–1993. doi: 10.1016/j.gendis.2022.08.014

Table 1.

Expression and biological function of TP53BP2 in different tumors.

Tumor types TP53BP2 expression in tumor Biological function References
Hepatocellular carcinoma Lower expression Promote proliferation, autophagy and chemotherapeutic drug resistance; Associated with patient prognosis and survival 11,47,48,49,50,51,52,53,54
Breast cancer Lower expression Promote proliferation and migration 13,53
Gastric cancer Lower expression Promote proliferation, migration, cell polarity and EMT 16,38,59
Endometrial endometrioid adenocarcinoma Lower expression TP53BP2 might become candidate markers for the early diagnosis of EEA 60
Oral cancer Lower expression Associated with advanced and moderately differentiated disease 61
Spinal tumor Lower expression Promote proliferation 62
Endometrial cancer Lower expression Promote cell migration 36
Esophageal squamous cell carcinoma Lower expression Promote ESCC generation and migration 63
Colorectal cancer Lower expression Promote proliferation 64
Renal cell carcinoma Lower expression Promote proliferation; Associated with patient prognosis 12
Gallbladder cancer Lower expression Promote cell migration; Associated with patient prognosis 65
Pancreatic cancer Lower expression Promote proliferation and chemotherapeutic drug resistance 66